Background {#Sec1}
==========

Zika Virus (ZIKV) is a single-stranded positive sense RNA *Flavivirus* \[[@CR1]\] that is primarily transmitted though the *Aedes* mosquito \[[@CR2]\]. Until recently this virus had remained relatively obscure, with the exception of a few scattered outbreaks \[[@CR1]--[@CR3]\]. Currently, 26 countries across South and Central America have reported widespread ZIKV infections, with cases also emerging in Europe and the United States \[[@CR4]\]. Typically, adult ZIKV infections are mild or asymptomatic, with exanthema, fever, conjunctivitis, and joint pain being the most common symptoms \[[@CR2], [@CR5]\]. However, ZIKV infection is also believed to be related to the concurrent increase in adult Guillain--Barré syndrome (GBS) cases \[[@CR4]\]. This is supported by a case controlled prospective study of the French Polynesian outbreak, where ZIKV was linked with increased incidence of GBS \[[@CR3]\]. Aside from its effects in adults, ZIKV infection of pregnant women can result in birth defects ranging from low birth weight to craniofacial and eye abnormalities \[[@CR6]\], as well as microcephaly \[[@CR7], [@CR8]\]. The detection of ZIKV in fetal brain tissues indicates that ZIKV can also cross the placental barrier \[[@CR9]\]. Consequently, curbing the current ZIKV epidemic has become a top priority for a number of international health initiatives.

Prompt laboratory-based efforts by Tang et al. provided RNA-seq data (GEO: GSE78711) from ZIKV-infected human neural progenitor cells (hNPCs). They found that when compared to neurons and embryonic stem cells, ZIKV infects hNPCs with high efficiency, and that infection results in abnormal cell cycle dynamics and apoptosis \[[@CR9]\]. For the current study, we analyzed this dataset using bioinformatic methods to uncover links between neuro-inflammatory pathways and ZIKV infection of hNPCs, as well as its correlation with clinical neurological symptoms. Since congenital CMV infection is also associated with higher incidence of neurological birth defects \[[@CR10]\], a CMV-infected hNPC dataset (GEO: GSE19345) was used for comparison \[[@CR11]\]. We demonstrate for the first time that ZIKV activates several inflammatory signals within infected hNPCs that are implicated in both innate and acquired immune responses. Moreover, several genes related to pathogen responses are significantly up-regulated in response to ZIKV infection, but not perturbed in CMV-infected hNPCs. Our approach offers novel insight into the potential mechanisms underlying ZIKV infection and provides useful directions for future clinical research.

Results {#Sec2}
=======

Comprehensive gene set gene ontology analysis {#Sec3}
---------------------------------------------

Comparison of the mock-infected samples to the ZIKV-infected samples using a modified *t*-test yields a total of 3443 genes up-regulated and 3421 down-regulated. The top 30 highest absolute fold-change (FC) genes are reported in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"} along with their associated Entrez IDs and p-values. Gene Ontology (GO) term analysis showed that the up-regulated gene set was exclusively enriched in processes related to nucleic acid metabolism regulation (Fig. [1](#Fig1){ref-type="fig"}a). Since replication of the viral genome requires reallocation of host nucleotides \[[@CR12]\], this finding was unsurprising. Also, the down-regulated gene set was enriched for DNA metabolism processes, although with emphasis on cell cycle regulation. These findings were consistent with evidence showing ZIKV infection results in the down-regulation of cell cycle genes, impaired cell cycle progression through G~1~ \[[@CR9]\], and decreased proliferation \[[@CR13]\] in vitro. Of the ZIKV down-regulated genes, the biological process most enriched proved to be chromosome segregation. This finding provides an interesting link to known causes of hereditary microcephaly, as abnormal brain development and reduced volume often are the result of dysregulation of chromosome segregation \[[@CR14], [@CR15]\].Table 1Top 30 genes up-regulated in ZIKV infected hNPCs compared to controlsGene symbolEntrezGene nameLog2 FCp valueIFIT23433Interferon-induced protein with tetratricopeptide repeats 25.229670.0051TNFRSF148764Tumor necrosis factor receptor superfamily, member 143.44670.00005BHLHE4179365Basic helix-loop-helix family, member e413.411930.00005SNORD116-4100033416Small nucleolar RNA, C/D box 116-43.35410.00065CEBPB1051CCAAT/enhancer binding protein (C/EBP), beta3.086080.00005SEC24D9871SEC24 family, member D (*S*. *cerevisiae*)3.066480.00005CHAC179094ChaC, cation transport regulator homolog 1 (*E. coli*)2.988020.00005CREB3L190993cAMP responsive element binding protein 3-like 12.97180.00005DDIT31649DNA-damage-inducible transcript 32.941720.00005STC28614Stanniocalcin 22.854460.00005IL20RB53833Interleukin 20 receptor beta2.743020.00005ADM279924Adrenomedullin 22.737910.00005DDR24921Discoidin domain receptor tyrosine kinase 22.682830.00005ULBP180329UL16 binding protein 12.65890.00005SLC7A1123657Solute carrier family 7 (anionic amino acid transporter light chain, xc-system), member 112.558550.00005GABRR22570Gamma-aminobutyric acid (GABA) A receptor, rho 22.546970.00025FOSL18061FOS-like antigen 12.546260.00005RELB5971v-rel reticuloendotheliosis viral oncogene homolog B2.521670.00005BHLHE408553Basic helix-loop-helix family, member e402.502780.00005INHBE83729Inhibin, beta E2.484160.00005XBP17494X-box binding protein 12.483920.00005SELPLG6404Selectin P ligand2.476280.00005SLC7A58140Solute carrier family 7 (amino acid transporter light chain, L system), member 52.442830.00005ARHGAP964333Rho GTPase activating protein 92.428990.00005HERPUD19709Homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 12.385250.00005KLF1528999Kruppel-like factor 152.366330.00005CDC42EP111135CDC42 effector protein (Rho GTPase binding) 12.350730.00005CEBPD1052CCAAT/enhancer binding protein (C/EBP), delta2.349790.00025GAL3ST264090Galactose-3-*O*-sulfotransferase 22.315890.0021FAM129A116496Family with sequence similarity 129, member A2.288080.00005Table 2Top 30 genes down-regulated in ZIKV infected hNPCs compared to controlsGene symbolEntrezGene nameLog2 FCp-valueSIGLEC1089790Sialic acid binding Ig-like lectin 10−3.606640.00005CDC20B166979Cell division cycle 20 homolog B (*S*. *cerevisiae*)−3.440830.0002OR51E281285Olfactory receptor, family 51, subfamily E, member 2−3.057420.0001CCNO10309Cyclin O−3.005620.00005SLCO4A128231Solute carrier organic anion transporter family, member 4A1−2.975080.0229SGPP2130367Sphingosine-1-phosphate phosphatase 2−2.690250.00035RRM26241Ribonucleotide reductase M2−2.637830.00005SFXN2118980Sideroflexin 2−2.616720.00005COLEC1281035Collectin sub-family member 12−2.604580.00005CHRNA11134Cholinergic receptor, nicotinic, alpha 1 (muscle)−2.56880.00005PRR22163154Proline rich 22−2.546830.00045DHFR1719Dihydrofolate reductase−2.531450.00005MFI24241Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5−2.507480.00005MAPK15225689Mitogen-activated protein kinase 15−2.462030.00005C21orf5854058Chromosome 21 open reading frame 58−2.396970.00005SPEF125876Sperm flagellar 1−2.395650.00005GHRL51738Ghrelin/obestatin prepropeptide−2.358040.00805ATG16L289849Autophagy related 16-like 2 (*S*. *cerevisiae*)−2.342250.00005CXCL149547Chemokine (C-X-C motif) ligand 14−2.331890.0015SUSD256241Sushi domain containing 2−2.288980.00005C6orf118168090Chromosome 6 open reading frame 118−2.279870.00005DLX6-AS1285987DLX6 antisense RNA 1−2.266620.00005ADAM2810863ADAM metallopeptidase domain 28−2.259060.00005NXPH211249Neurexophilin 2−2.228560.00005AQP7P1375719Aquaporin 7 pseudogene 1−2.22550.00005EFCAB179645EF-hand calcium binding domain 1−2.199180.00005WNT8B7479Wingless-type MMTV integration site family, member 8B−2.193660.00005PI1551050Peptidase inhibitor 15−2.176150.00005C1orf189388701Chromosome 1 open reading frame 189−2.175310.01255OLFML356944Olfactomedin-like 3−2.168350.0016Fig. 1Comprehensive gene set gene ontology analysis. Gene ontology analysis was performed on hNPC genes whose expression was significantly altered following infection with ZIKV for 56 h. Transcript enrichment significance was determined using the human protein coding genome as the reference background. **a** Regulation of nucleic acid metabolism was the only biological process sub-ontology enriched with ZIKV up-regulated genes. Down-regulated genes were enriched for pathways related to cell cycle regulation and general metabolism. All significant terms are presented. **b** Cellular component enrichment indicated down-regulated genes generally associated with chromosomal regions, the extracellular matrix, and centrosomes. Up-regulated genes showed the most enrichment for the Golgi apparatus. Both up- and down-regulated genes were significantly enriched in nuclear sites. Enrichment scores were sorted by the most significant terms, and the top 11 compartments are represented. (q \< 0.05)

By also assessing cellular compartment sub-ontology, we elucidated the cellular location of the infection induced gene expression alterations (Fig. [1](#Fig1){ref-type="fig"}b). Genes down-regulated by ZIKV were highly enriched in centromeric and nuclear sites, the extracellular matrix, and mitochondria. Furthermore, down-regulated genes were associated with exosomes, suggesting that the infection can influence exosome biology. Up-regulated genes were enriched specifically in the Golgi complex, the cytoplasm, and the monocytic leukemia zinc-finger protein/related factor (MOZ/MORF) histone acetyltransferase complex, which serves as a regulator of neural and hematopoietic stem-cell identity \[[@CR16]\].

ZIKV DEGs represented in canonical human neurological diseases {#Sec4}
--------------------------------------------------------------

To investigate whether ZIKV induced differentially expressed genes (DEGs) are related to the observed clinical phenotypes, comparisons were made between significant ZIKV DEGs and those related to the pathogenesis of human neurological diseases (Fig. [2](#Fig2){ref-type="fig"}) (Table [3](#Tab3){ref-type="table"}). Considering that hNPCs were used for the RNA-seq study, our inquiry was limited to diseases of the nervous system. Using the MalaCards \[[@CR17]\] integrated searchable database of human diseases, we selected six conditions for comparison. Each condition is a parent disease relating sub-categories of more specific diseases. For each condition, the number of ZIKV DEGs present in the MalaCards reference list is reported as the represented percentage. The number of total genes in each MalaCards reference list is plotted along the second y-axis (scatterplot). The condition with the most representation proved to be microcephaly, with 70 % of the 30 reference list genes present in the ZIKV DEGs. Since, epilepsy is a common microcephaly co-morbidly \[[@CR18]\], it was unsurprising to discover there was 43 % representation of related genes. The more general group of congenital nervous system disorders also displayed a similarly high representation of ZIKV DEGs at 60 % of the total reference list. Since, there has also been an increase in reported cases of adult GBS in ZIKV affected areas \[[@CR2], [@CR3]\], we investigated encephalitis, demyelinating diseases, and GBS specifically. While representation of ZIKV DEGs in these disease classifications were present, it was significantly less than congenital central nervous system (CNS) diseases.Fig. 2ZIKV DEGs mapped to canonical human disease gene sets. Using the MalaCards database of human diseases, diseases with established clinical significance to ZIKV infection were queried. ZIKV DEGs were then compared to reference gene list for each disease to determine a percentage of representation. Diseases related to congenital CNS disorders were most highly represented with ZIKV DEGs. Although less, representation of adult inflammatory and demyelinating diseases were also observed. (*Bars* % of ZIKV induced genes present in the reference list) (*Open circles* total number of genes in the disease reference list)Table 3Neurological clinical phenotypes associated with ZIKV DEGsDiseaseGene symbolGene nameMicrocephalyDYRK1ADual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1AMCPH1Microcephalin 1CASKCalcium/calmodulin-dependent serine protein kinase (MAGUK family)PHGDHPhosphoglycerate dehydrogenaseARFGEF2ADP-ribosylation factor guanine nucleotide-exchange factor 2ASPMAsp (abnormal spindle) homolog, microcephaly associatedCENPJCentromere protein JCEP152Centrosomal protein 152 kDaSLC25A19Solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19WDR62WD repeat domain 62CDK5RAP2CDK5 regulatory subunit associated protein 2CASC5Cancer susceptibility candidate 5NBNNibrinEFTUD2Elongation factor Tu GTP binding domain containing 2IER3IP1Immediate early response 3 interacting protein 1STILSCL/TAL1 interrupting locusCEP135Centrosomal protein 135 kDaZNF335Zinc finger protein 335NDE1nudE nuclear distribution E homolog 1DIAPH1Diaphanous homolog 1KIF11Kinesin family member 11Congenital nervous system disordersMCPH1Microcephalin 1ARFGEF2ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited)TGIF1TGFB-induced factor homeobox 1GRIN2BGlutamate receptor, ionotropic, *N*-methyl [d]{.smallcaps}-aspartate 2BSLC12A5Solute carrier family 12 (potassium/chloride transporter), member 5FLNAFilamin A, alphaSIX3SIX homeobox 3SHHSonic hedgehogCDK5RAP2CDK5 regulatory subunit associated protein 2NDE1nudE nuclear distribution E homolog 1WDR62WD repeat domain 62ASPMAsp (abnormal spindle) homolog, microcephaly associatedCENPJCentromere protein JSTILSCL/TAL1 interrupting locusFKTNFukutinPOMGNT1Protein O−linked mannose beta1,2−N−acetylglucosaminyltransferaseCEP152Centrosomal protein 152 kDaPOMT2Protein−O−mannosyltransferase 2GLI2GLI family zinc finger 2ZNF335Zinc finger protein 335Epilepsy syndromeCDKL5Cyclin−dependent kinase−like 5CSTBCystatin B (stefin B)TSC1Tuberous sclerosis 1CACNB4Calcium channel, voltage−dependent, beta 4 subunitCLCN2Chloride channel, voltage−sensitive 2PCDH19Protocadherin 19KCNQ2Potassium voltage−gated channel, KQT−like subfamily, member 2CLN5Ceroid−lipofuscinosis, neuronal 5ATP1A2ATPase, Na +/K + transporting, alpha 2 polypeptideLGI1Leucine−rich, glioma inactivated 1SCN1BSodium channel, voltage−gated, type I, beta subunitALDH5A1Aldehyde dehydrogenase 5 family, member A1EFHC1EF−hand domain (C−terminal) containing 1EncephalitisDDX58DEAD (Asp−Glu−Ala−Asp) box polypeptide 58RPSARibosomal protein SATREX1Three prime repair exonuclease 1Demyelinating diseasePLP1Proteolipid protein 1RTN4Reticulon 4GALCGalactosylceramidaseGBSFASFas (TNF receptor superfamily, member 6)

GO network mapping reveals connections between hNPC ZIKV infection and the immune system {#Sec5}
----------------------------------------------------------------------------------------

A wide variety of cell types outside the traditional immune system can respond to the threat of pathogens \[[@CR19]\]. Thus, investigations were conducted to determine if infected hNPCs presented a pattern of gene expression consistent with a defense response. To visualize the intracellular networks regulating expression changes, a GO network map was generated (Fig. [3](#Fig3){ref-type="fig"}). All significant ZIKV DEGs greater than 0.5 absolute log fold-change were loaded into Cytoscape \[[@CR20]\], and gene ontology clustering was performed with the ClueGO plugin \[[@CR21]\]. The human genome was used as the background with GO biological process and immune system terms queried for enrichment. GO terms for biological processes are denoted with a circle, while GO immune system terms are denoted with a triangle. As expected, nucleic acid metabolic processes were heavily enriched and connected, representing the majority of the network and indicating that they are not a directly connected to the immune system terms. Of the eight main networks identified, four were associated with immune system response. The identified networks were immune response, cytokine production, leukocyte activation, and defense response to other organisms. Additionally, cell cycle, negative regulation of macromolecule biosynthetic process, and cellular macromolecule metabolic process terms were represented.Fig. 3Gene ontology functional network of biological process and immune system terms. All significantly altered genes greater than 0.5 fold-change were imported into Cytoscape and Gene Ontology clustering was performed with the ClueGO plugin. The human genome was used as the background with the GO biological process and immune system terms queried for enrichment. Terms were generated such that GO Term Fusion was implemented on pathways with a less than 0.01 q-value. Groupings with less than 3 connections were excluded from the final list of networks. Terms related to cytokine and chemokine production as well as general pathogen response formed networks independent of nucleic acid and macromolecule metabolic processes

Gene expression in ZIKV-infected hNPCs differs from the expression profile of CMV-infected hNPCs {#Sec6}
------------------------------------------------------------------------------------------------

A number of common human viruses are known to infect fetal NPCs, such as Herpes simplex virus 1 (HSV-1), CMV, human immunodeficiency virus (HIV), and Varicella-zoster virus (VZV), and are linked to the development of severe birth defects \[[@CR6], [@CR9], [@CR11], [@CR13], [@CR22]--[@CR24]\]. To explore if the alterations in immune related gene expression seen in ZIKV-infected hNPCs was consistent with other viral infections, we compared the ZIKV expression profile to that of CMV-infected human induced pluripotent stem (iPS) derived NPCs. This gene set provided well matched data for comparison, since the hNPCs in both studies were derived from iPS cells and implement Illumina transcript analysis \[[@CR9], [@CR23]\]. Additionally, hNPCs have demonstrated permissiveness to both viruses and infection in early fetal development with either virus has been linked to similar congenital neurological defects \[[@CR9], [@CR11], [@CR23], [@CR24]\].

The significant CMV related DEGs were analyzed in the same manner as the ZIKV related DEGs, such that the significant biological pathways are reported as fold enrichment. Clustering the pathways enriched by either CMV or ZIKV infection revealed apparent differences in the functional pathway enrichment patterns (Fig. [4](#Fig4){ref-type="fig"}). Forced clustering by functional pathway was used with hierarchical clustering within the groups implemented by rows. When hierarchical clustering is applied to columns, ZIKV up- and down-regulated gene pathways showed stronger similarity to each other than to CMV altered pathways (Fig. [4](#Fig4){ref-type="fig"}a). Examination of the cytokine/chemokine specific pathways likewise indicated divergent expression profiles between viruses (Fig. [4](#Fig4){ref-type="fig"}b). Several cytokine-regulated pathways were activated in ZIKV-infected NPCs, while CMV-infected hNPCs showed limited representation of these pathways. Interleukin-5 (IL-5), granulocyte-macrophage colony-stimulating factor (GM-CSF), and interleukin-3 (IL-3) mediated signaling were comparably enriched but associated with the down regulated genes in CMV but with the up regulated genes in the CMV set. Additionally, the pathogen response pathways highly represented in the ZIKV altered genes are not significantly enriched in either the CMV up or down regulated gene sets (Fig. [4](#Fig4){ref-type="fig"}c). While both viruses can infect hNPCs and cause comparable birth defects, the apparent mechanism by which these birth defects are caused appears to be unrelated between viruses.Fig. 4Divergent gene expression patterns in CMV and ZIKV-infected hNPCs. Genes significantly different between mock and cells infected with either CMV or ZIKV were processed identically and resulting significant biological pathways were mapped. Clustering was performed on the resulting pathways such that similar functions were grouped for clarity. The Cytokine/Chemokine and Pathogen Response clusters were enlarged to demonstrate the divergent pathway enrichment between ZIKV and CMV infection

Immune and inflammatory responses in ZIKV-infected hNPCs {#Sec7}
--------------------------------------------------------

Given that the immune response gene enrichment seen in ZIKV-infected hNPCs differed from CMV infection, we further investigated the potential inflammatory pathways involved. Inspection of the biological pathways significantly enriched for ZIKV DEGs revealed a pattern of immunological term enrichment in genes up-regulated by the virus. Using search terms classifying immune related pathways our query returned 24 immune related pathways out of the 178 total in the ZIKV up-regulated genes (Fig. [5](#Fig5){ref-type="fig"}a). Of the 119 significantly enriched pathways of genes down-regulated by ZIKV infection, none were related to immune function (Fig. [5](#Fig5){ref-type="fig"}a). Among the inflammatory pathways identified from the up-regulated genes, were the endosomal viral pathogen recognizing Toll-like receptor (TLR) 9 and TLR7/8 pathways which recognize CpG containing DNA and ssRNA, respectively \[[@CR25]\]. TLR receptor signaling is primarily mediated through the adaptor protein myeloid differentiation primary response gene 88 (MyD88) in response to infection \[[@CR26]\]. Other TLRs are located on the plasma membrane and recognize a wide variety of pathogen associated molecules \[[@CR25]\] and were thus classified as pathogen response pathways. Additionally, several canonical inflammatory pathways were activated, including tumor necrosis factor (TNF) receptor pathways, interferon gamma (IFN-γ) signaling pathway, pathways involved in interleukin (IL)-1, IL-2, IL-3, IL-5, IL-6, IL-12, IL-23, C-X-C motif chemokine 12 (CXCL12)/CXCR4, pathway and GM-CSF mediated pathway (Fig. [5](#Fig5){ref-type="fig"}b).Fig. 5Immune specific biological pathways enriched in up-regulated genes. **a** The biological pathways associated with ZIKV transcript changes were filtered to include top immune specific pathways. **b** Using a FDR q-value \<0.05, several top immune function pathways were enriched for the up-regulated gene set, although none of the pathways were enriched for significant down-regulated transcripts. The q-values for the pathway enrichment are annotated along the *left panel* as the *dot plot*. **c** Using tissue specific expression databases, up- and down-regulated genes were probed for immune related cells and tissues. Innate and adaptive immune system components were represented in both lists. (*q* \< *0.05*)

Cell and tissue type analysis of the whole ZIKV DEG gene set revealed representation of tissue types associated with immune and hematological function (Fig. [5](#Fig5){ref-type="fig"}c). Tissue and cell types exclusively associated with ZIKV up-regulated genes included the bone marrow, erythrocytes, and platelets. B-cells and dendritic cells were the only cell types exclusive to the down-regulated gene set. Both up- and down-regulated genes were enriched for monocytes, T-cells, leukocytes, and the thymus. The immune specific enrichment of the genes differentially expressed in ZIKV-infected hNPCs indicate involvement of both the innate and adaptive immune system. Dendritic cells are important antigen-presenting cells (APC) while T- and B-cells are primarily responsible for adaptive response. This enrichment points to a role for ZIKV inducing NPCs to take on a yet unclear immune-modulating phenotype.

Analysis of cytokine/chemokine associated intracellular signaling pathways {#Sec8}
--------------------------------------------------------------------------

The two major immune cell pathways that control the production of inflammatory cytokines can be classified as being nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and signal transducer and activator of transcription (STAT) protein family dependent. Both NF-κB and STAT family-members are transcription factors that induce gene expression upon stimulation by wide variety of ligands. Figure [6](#Fig6){ref-type="fig"} illustrates simplified versions of these pathways activated in ZIKV-infected NPCs. The pathogens (represented as pathogen-associated molecular patterns, PAMP) and TLR 7/8/9 pathways enriched in the ZIKV up-regulated genes (Fig. [4](#Fig4){ref-type="fig"}), induce gene expression primarily through nuclear translocation of NF-κB. Other NF-κB mediated pathways enriched in ZIKV up-regulated genes were C-X-C chemokine receptor type 4 (CXCR4), CD40, TNF, and IL-1 signaling (Fig. [4](#Fig4){ref-type="fig"}). STAT family induced genes can also result in inflammatory cytokine production upon activation of plasma membrane receptors. The enriched STAT family related signaling pathways were IFN-γ, IL-6, and IL-12 in the ZIKV up-regulated genes (Fig. [4](#Fig4){ref-type="fig"}).Fig. 6Activation of NF-κB and STATs signaling pathway in ZIKV-infected hNPCs. Cytokines (IL-1 and TNF-α), PAMPs, CD40 and CXCL12 interact with their receptors resulting in activation of the NF-κB pathway. IFN-γ, IL-6 and IL-12 binding to their receptors induces STAT dimerization and translocation to the nucleus. Activation of both the canonical NF-κB and STAT signaling pathways, results in the production of numerous inflammatory cytokines.

Discussion {#Sec9}
==========

Our results show that collectively, ZIKV induced transcriptomic alterations are associated with established clinical pathologies. Following viral infection there is a reallocation of host nucleic acids and other metabolites towards viral specific replication processes \[[@CR12]\], thus the enrichment of biological processes related to nucleic acid metabolism is an expected finding, as well as the enrichment of cell cycle regulation. The cell cycle perturbations of infected cells suggest the initiation of a G~1~/S checkpoint and impaired progression through G~1~ \[[@CR9]\]. A possible explanation for these cell cycle abnormalities could be inhibition of S-phase progression due to limited nucleic acid reserves as the virus reallocates them for its own replication. Down-regulation of critical epigenetic markers represents a possible driver for abnormal gene expression in infected cells. If NPCs in the developing human brain are diverted from normal development, it can result in conditions like microcephaly. Moreover, this raises questions about the possible long-term neurological effects in adult following ZIKV infection of adult neural progenitors. Although, the ZIKV associated clinical phenotypes were highly enriched for congenital CNS disorders, comparatively few genes were associated with adult CNS inflammation and demyelination diseases. This may be the due to the fact that the current study implemented the MR766 Ugandan isolate which has not been associated with an increased incidence of GBS and myelitis. As a result, future studies that employ more neoteric strains will likely observe increased representation of related genes.

The significant enrichment of canonical immune system pathways in ZIKV-infected hNPCs proved to be another unexpected finding. Our study provides evidence at the transcriptional level that two major mediators of inflammation, NF-κB and the STAT family of proteins, regulate inflammatory response in hNPCs. NF-κB is one of the main transcriptional factors activated in response to pro-inflammatory cytokines, such as TNF-α and IL-1. It is also triggered by TLRs via pathogen-associated molecular patterns (PAMPs). The Janus Kinase (JAK)-Signal transducer and activator of transcription (STAT) pathway is also a major signaling pathway that regulates inflammation and mediates the responses of target cells to inflammatory cytokines. Activation of these pathways has a central role in inflammation through the regulation of genes encoding pro-inflammatory cytokines, chemokines, and inducible enzymes such as cyclooxygenase-2 (COX2) and inducible nitric oxide synthase (iNOS) \[[@CR27]\]. Moreover, it has recently been reported that ZIKV-infected fetal brains display a number of inflammatory markers, including diffuse astrogliosis, and activations of macrophages and microglia \[[@CR9]\]. It is conceivable that ZIKV-infected NPCs may exert immunomodulatory and inflammatory effects on CNS cells such as neurons as well as astrocytes in an autocrine, paracrine, and juxtacrine manner, thus amplifying brain inflammation. Interestingly, although congenital CMV infection can also result in microcephaly and general impaired brain development \[[@CR24]\], the inflammatory signals were not observed in CMV-infected hNPCs. The significance of this is still under investigation.

With the currently limited molecular data regarding transcriptomic alterations in infected host cells, large scale analysis is difficult. In spite of this, we present analysis of the currently available data in an effort to guide future studies. The RNA-seq was performed on only one infected cell type, hNPCs, thus we implemented stringent Benjamini Hochberg (BH) \[[@CR28]\] false discovery rate (FDR) q-value cut-offs to limit false positives in enriched pathways. The use of the older MR766 isolate for the experiments likewise limits extrapolation of the results, even though it shares 88.9 % nucleotide and 96.5 % amino acid identity with the current strain \[[@CR29]\]. Considering that reported pathogenicity has been increasing over time, the presented data likely represents a milder host response should any host transcript differences exist.

Conclusion {#Sec10}
==========

In conclusion, we report that ZIKV infection induces alterations to NPC immune response gene expression. While the primary infection typically occurs through the bite of an infected mosquito, the mechanism for entry into the restricted CNS is currently unclear. Presumably the specific physiology of the fetal blood brain barrier is permissible to ZIKV as it is to other viruses \[[@CR24]\]. Regardless, it has been shown that the virus can infect NPCs with high efficiency leading to increased apoptosis \[[@CR9]\]. In addition, the presented study is the first to report enrichment of numerous pro-inflammatory pathways in ZIKV-infected hNPCs, indicating that hNPCs are capable of activating pro-inflammatory immune system pathways following viral infections. This represents, in addition to direct activation of apoptotic pathways, a mechanism by which the virus could induce cell death via the propagation a cytotoxic pro-inflammatory environment in the CNS. Although it is possible that ZIKV can infect immune cells in a similar manner as the related Dengue virus \[[@CR30]--[@CR33]\], the ability of ZIKV to infect hNPCs may exacerbate CNS inflammation. Consequently, a better understanding of the cellular and molecular mechanisms regulation of the cross-talk between NPCs, CNS resident cells, and immune cells may be crucial for the development of effective strategies to treat ZIKV infection.

Methods {#Sec11}
=======

Gene sets and expression analysis {#Sec12}
---------------------------------

We analyzed the transcriptomic sequencing (RNA-seq) data (GEO: GSE78711) of ZIKV (MR766) infected human neural progenitor cells (hNPCs). Briefly, Tang et al. infected hNPCs derived from human induced pluripotent stem (iPS) cells with ZIKV. The infected hNPCs were incubated for 56 h, a time frame already proven sufficient for a greater than 60 % infection rate. RNA extracted from ZIKV-infected samples and mock infected samples was used for library generation and sequencing \[[@CR9]\]. For comparison to the ZIKV-infected hNPCs, the expression data from iPCS derived NPCs infected with human CMV (Ad169) was implemented (GEO: GSE35295). The cells were infected with CMV, and the RNA was extracted 24 after infection for analysis on an Illumina HumanHT-12 V4.0 expression beadchip. Three biological replicates for control and infected cells were used, and a list of significantly altered genes were generated with a BH FDR q-value cut-off of \< 0.05 \[[@CR23]\].

Availability of data and materials {#Sec13}
----------------------------------

The datasets supporting the conclusions of this article are available in the gene expression omnibus (GEO) repository, <http://www.ncbi.nlm.nih.gov/geo/>.

Biological process and cellular compartment analysis {#Sec14}
----------------------------------------------------

Using FunRich \[[@CR34]\], up- and down-regulated genes with associated Log~2~ FCs were analyzed for enrichment against the human annotated genome. Biological process, cellular compartment, and biological pathway significance was defined as a FDR q-value less than 0.05. All significant biological processes were presented. All 11 significant cellular compartments for the ZIKV up-regulated genes were presented, along with the top 11 most significant pathways enriched for ZIKV down-regulated genes.

Subsetting for immune specific biological pathway enrichment {#Sec15}
------------------------------------------------------------

The significant biological pathways associated with both ZIKV up- and down-regulated genes were filtered such that non-immune specific biological pathways were excluded. Significance was defined as a FDR q-value less than 0.05.

ZIKV genes associated with clinical phenotypes {#Sec16}
----------------------------------------------

Clinically relevant diseases associated with ZIKV DEGs were queried using the MalaCards \[[@CR17]\] integrated database of human diseases. The absolute percentage of ZIKV DEGs present in the reference list derived from MalaCards was reported, as well as the total number of genes in the reference list.

Gene ontology network analysis {#Sec17}
------------------------------

DEGs with an absolute fold change greater than 0.5 were imported to Cytoscape \[[@CR20]\], where Gene Ontology clustering was performed using the ClueGO plugin \[[@CR21]\]. The human genome was used as the background, and the GO biological process and GO immune system terms were queried for enrichment. Terms were generated such that GO Term Fusion was implemented for pathways with a less than 0.01 FDR q-value. Groups with less than three connections were excluded from the final network.

R packages {#Sec18}
----------

Heatmaps generated with the Bioconductor package ComplexHeatmap \[[@CR35]\] within the R statistical computing environment \[[@CR36]\].

ZIKV

:   Zika virus

iPSC

:   induced pluripotent stem cell

hNPC

:   human neural progenitor cell

CMV

:   cytomegalovirus

GBS

:   Guillain--Barré syndrome

GO

:   gene ontology

FC

:   fold-change

MOZ/MORF

:   monocytic leukemia zinc-finger protein/related factor

DEG

:   differentially expressed genes

CNS

:   central nervous system

HSV-1

:   herpes simplex virus 1

HIV

:   human immunodeficiency virus

VZV

:   varicella-zoster virus

GM-CSF

:   granulocyte--macrophage colony stimulating factor

IL

:   interleukin

TLR

:   toll-like receptor

MyD88

:   myeloid differentiation primary response gene 88

TNF

:   tumor necrosis factor

IFN

:   interferon

CXC

:   C-X-C motif chemokine

APC

:   antigen-presenting cells

STAT

:   signal transducer and activator of transcription

NF-κB

:   nuclear factor kappa-light-chain-enhancer of activated B cells

PAMP

:   pathogen-associated molecular patterns

JAK

:   Janus kinase

COX2

:   cyclooxygenase-2

iNOS

:   inducible nitric oxide synthase
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